Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 239,455 | 200,489 | 184,733 | 201,267 | 186,038 |
| Cost of Goods | 59,650 | 38,153 | 31,994 | 54,409 | 42,778 |
| Gross Profit | 179,805 | 162,336 | 152,739 | 146,858 | 143,260 |
| Operating Expenses | 114,968 | 114,309 | 97,488 | 91,540 | 82,328 |
| Operating Income | 65,487 | 48,180 | 56,245 | 55,727 | 61,710 |
| Interest Expense | 3,621 | 3,646 | 3,836 | 4,209 | 4,348 |
| Other Income | 5,624 | 5,103 | 4,768 | 4,637 | 4,808 |
| Pre-tax Income | 67,490 | 49,637 | 57,177 | 56,155 | 62,170 |
| Income Tax | 16,625 | 9,861 | 11,617 | 6,680 | 16,077 |
| Net Income Continuous | 50,865 | 39,776 | 45,560 | 49,475 | 46,093 |
| Net Income | $50,865 | $39,776 | $45,560 | $49,475 | $46,093 |
| EPS Basic Total Ops | 0.88 | 0.69 | 0.79 | 0.87 | 0.81 |
| EPS Basic Continuous Ops | 0.88 | 0.69 | 0.80 | 0.87 | 0.81 |
| EPS Diluted Total Ops | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 |
| EPS Diluted Continuous Ops | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 |
| EPS Diluted Before Non-Recurring Items | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 |
| EBITDA(a) | $71,280 | $53,857 | $61,928 | $61,373 | $67,303 |